<SEC-DOCUMENT>0001140361-26-020557.txt : 20260511
<SEC-HEADER>0001140361-26-020557.hdr.sgml : 20260511
<ACCEPTANCE-DATETIME>20260511161051
ACCESSION NUMBER:		0001140361-26-020557
CONFORMED SUBMISSION TYPE:	S-8 POS
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260511
DATE AS OF CHANGE:		20260511
EFFECTIVENESS DATE:		20260511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kezar Life Sciences, Inc.
		CENTRAL INDEX KEY:			0001645666
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				473366145
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8 POS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-277939
		FILM NUMBER:		26963308

	BUSINESS ADDRESS:	
		STREET 1:		4000 SHORELINE COURT, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-822-5600

	MAIL ADDRESS:	
		STREET 1:		4000 SHORELINE COURT, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8 POS
<SEQUENCE>1
<FILENAME>ef20072571_s8pos.htm
<DESCRIPTION>S-8 POS
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">


  <div>
    <div style="text-align: center; font-weight: bold;">As filed with the Securities and Exchange Commission on May 11, 2026</div>
    <div><br>
    </div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-225769</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-230520</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-237133</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-254161</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-263659</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-271841</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-277939</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-286084</div>
    <div style="text-align: right; font-weight: bold;"> <br>
    </div>
    <div>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div> <br>
      </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-225769</div>
    <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-230520</div>
    <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-237133</div>
    <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-254161</div>
    <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-263659</div>
    <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-271841</div>
    <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-277939</div>
    <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-286084</div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM S-8</div>
    <div style="text-align: center; font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; font-style: italic; font-weight: bold;">UNDER</div>
    <div style="text-align: center; font-style: italic; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
    <div> <br>
      </div>

    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: center; font-size: 24pt; font-weight: bold;">KEZAR LIFE SCIENCES, INC.</div>
    <div style="text-align: center; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>
    <div> <br>
      </div>

    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <table cellspacing="0" cellpadding="0" border="0" id="zf0b190ec6e754fa0b69da14b4ebc5216" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">Delaware</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">&#160;</td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">47-3366145</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(State or other jurisdiction of incorporation or organization)</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">&#160;</td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(IRS employer identification number)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">4000 Shoreline Court, Suite 300</div>
    <div style="text-align: center; font-weight: bold;">South San Francisco, California 94080</div>
    <div style="text-align: center; font-weight: bold;">(Address of Principal Executive Offices, including Zip Code)</div>
    <div> <br>
      </div>

    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: center; font-weight: bold;">Kezar Life Sciences, Inc. <font style="color: rgb(0, 0, 0);">2015 Equity Incentive Plan</font></div>
    <div style="text-align: center; font-weight: bold;">Kezar Life Sciences, Inc. <font style="color: rgb(0, 0, 0);">2018 Equity Incentive Plan</font></div>
    <div style="text-align: center; font-weight: bold;">Kezar Life Sciences, Inc. <font style="color: rgb(0, 0, 0);">2018 Employee Stock Purchase Plan</font></div>
    <div style="text-align: center; font-weight: bold;">Kezar Life <font style="color: rgb(0, 0, 0);">Sciences, Inc. 2022 Inducement Plan</font></div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">(Full title of the Plans)</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-weight: bold;">Michael Hearne</div>
    <div style="text-align: center; font-weight: bold;">Chief Financial Officer</div>
    <div style="text-align: center; font-weight: bold;">Kezar Life Sciences, Inc.</div>
    <div style="text-align: center; font-weight: bold;">77 Upper Rock Circle, Suite 700</div>
    <div style="text-align: center; font-weight: bold;">Rockville, Maryland 20850</div>
    <div style="text-align: center; font-weight: bold;">(250) 744-2487</div>
    <div style="text-align: center; font-weight: bold;">(Name, Address and Telephone Number, including Area Code, of Agent for Service)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;"><font style="font-style: italic;">Copies to</font>:</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Andrew Marmer</div>
    <div style="text-align: center; font-weight: bold;">Jared Fertman</div>
    <div style="text-align: center; font-weight: bold;">Willkie Farr &amp; Gallagher LLP</div>
    <div style="text-align: center; font-weight: bold;">787 Seventh Avenue</div>
    <div style="text-align: center; font-weight: bold;">New York, NY 10019-6099</div>
    <div style="text-align: center; font-weight: bold;">(212) 728-8000</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Bill Roegge</div>
    <div style="text-align: center; font-weight: bold;">Rita Sobral</div>
    <div style="text-align: center; font-weight: bold;">Cooley LLP</div>
    <div style="text-align: center; font-weight: bold;">55 Hudson Yards</div>
    <div style="text-align: center; font-weight: bold;">New York, NY 10001-2157</div>
    <div style="text-align: center; font-weight: bold;">(212) 479-6000</div>
    <div> <br>
      </div>

    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
      growth company. See definitions of &#8220;large accelerated filer, &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
    <div> <br>
      </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z0d60ac424e234b4bb597576726854061" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 19.32%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Large accelerated filer</div>
          </td>
          <td style="width: 53%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9744;</div>
          </td>
          <td style="width: 24.67%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Accelerated filer</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.32%; vertical-align: middle;"><br>
          </td>
          <td style="width: 53%; vertical-align: middle;"><br>
          </td>
          <td style="width: 24.67%; vertical-align: middle;"><br>
          </td>
          <td style="width: 3%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 19.32%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Non-accelerated filer</div>
          </td>
          <td style="width: 53%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9746;</div>
          </td>
          <td style="width: 24.67%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Smaller reporting company</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9746;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.32%; vertical-align: middle;"><br>
          </td>
          <td style="width: 53%; vertical-align: middle;"><br>
          </td>
          <td style="width: 24.67%; vertical-align: middle;"><br>
          </td>
          <td style="width: 3%; vertical-align: middle;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 19.32%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 53%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 24.67%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Emerging growth company</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9744;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.&#160; &#9744;</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">EXPLANATORY NOTE</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">DEREGISTRATION OF UNSOLD SECURITIES</div>
    <div>&#160;</div>
    <div style="text-align: justify;">These Post-Effective Amendments (the &#8220;<u>Post-Effective Amendments</u>&#8221;) filed by Kezar Life Sciences, Inc., a Delaware corporation (the &#8220;<u>Registrant</u>&#8221;), to
      deregister all shares of the Registrant&#8217;s common stock, par value $0.001 per share (the &#8220;<u>Shares</u>&#8221;), remaining unissued under the following Registration Statements on Form S-8 (each, a &#8220;<u>Registration Statement</u>&#8221;, and collectively, the &#8220;<u>Registration
        Statements</u>&#8221;) filed by the Registrant with the U.S. Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;).</div>
    <div style="text-align: justify;"> <br>
      </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z9066e67015304e1a89e0d3f5defba999" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 3.99%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0);">&#8226;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 91.01%; vertical-align: top;">
            <div style="text-align: justify;"><font style="color: #000000;">Registration Statement on Form S-8 (No. </font>333-225769<font style="color: rgb(0, 0, 0);">) pertaining to the registration of (i) 2,102,045 options issuable under the Kezar Life Sciences, Inc. 2015 Equity Incentive Plan (the &#8220;2015 Plan&#8221;)</font>, (ii) 1,845,465<font style="color: rgb(0, 0, 0);"> Shares issuable under the Kezar Life Sciences, Inc. 2018 Equity Incentive Plan (the &#8220;2018 Plan&#8221;), (iii) 52,490 options issuable under the 2018 Plan and (iv) 200,000 Shares issuable under the Kezar Life Sciences, Inc. 2018 Employee Stock Purchase Plan
                  (the &#8220;</font><u><font style="color: rgb(0, 0, 0);">ESPP</font></u><font style="color: rgb(0, 0, 0);">&#8221;).</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.99%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0);">&#8226;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 91.01%; vertical-align: top;">
            <div style="text-align: justify;"><font style="color: #000000;">Registration Statement on Form S-8 (No. </font>333-230520<font style="color: rgb(0, 0, 0);">) pertaining to the registration of (i) 955,721 Shares issuable under the 2018 Plan and </font>(ii) 191,144<font style="color: rgb(0, 0, 0);">
                  Shares issuable under the ESPP.</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.99%; vertical-align: middle;">
            <div style="text-align: justify;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0);">&#8226;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 91.01%; vertical-align: top;">
            <div style="text-align: justify;"><font style="color: #000000;">Registration Statement on Form S-8 (No. </font>333-237133<font style="color: rgb(0, 0, 0);">) pertaining to the registration of (i) 960,403 Shares issuable under the </font>2018 Plan and (ii) 192,080 Shares issuable under the ESPP.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.99%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0);">&#8226;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 91.01%; vertical-align: top;">
            <div style="text-align: justify;"><font style="color: #000000;">Registration Statement on Form S-8 (No. </font>333-254161<font style="color: rgb(0, 0, 0);">) pertaining to the registration of (i) 2,317,987 Shares issuable under the </font>2018 Plan and (ii) 375,000 Shares issuable under the ESPP.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.99%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0);">&#8226;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 91.01%; vertical-align: top;">
            <div style="text-align: justify;"><font style="color: #000000;">Registration Statement on Form S-8 (No. </font>333-263659<font style="color: rgb(0, 0, 0);">) pertaining to the registration of (i) 2,812,987 Shares issuable under the 2018 Plan and </font>(ii) 375,000<font style="color: rgb(0, 0, 0);">
                  Shares issuable under the ESPP.</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.99%; vertical-align: middle;">
            <div style="text-align: justify;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0);">&#8226;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 91.01%; vertical-align: top;">
            <div style="text-align: justify;"><font style="color: #000000;">Registration Statement on Form S-8 (No. </font>333-271841<font style="color: rgb(0, 0, 0);">) pertaining to the registration of (i) 3,424,671 Shares issuable under the </font>2018 Plan, (ii) 1,995,000 Shares issuable under the Kezar Life
                Sciences, Inc. 2022 Inducement Plan (the &#8220;<u>2022 Plan</u>&#8221;) and (iii) 1,005,000 options under the 2022 Plan.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.99%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0);">&#8226;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 91.01%; vertical-align: top;">
            <div style="text-align: justify;"><font style="color: #000000;">Registration Statement on Form S-8 (No. </font>333-277939<font style="color: rgb(0, 0, 0);">) pertaining to the registration of 3,638,953 Shares issuable under the </font>2018 Plan.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.99%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 0);">&#8226;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 91.01%; vertical-align: top;">
            <div style="text-align: justify;"><font style="color: #000000;">Registration Statement on Form S-8 (No. </font>333-286084<font style="color: rgb(0, 0, 0);">) pertaining to the registration of 365,181 Shares issuable under the </font>2018 Plan.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">The Registrant is filing these Post-Effective Amendments to withdraw and remove any unissued and unsold securities issuable by the Registrant pursuant to the
      above-referenced Registration Statements.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="color: #000000;">On March
        30, 2026, the Registrant entered into an Agreement and Plan of Merger (the &#8220;<u>Merger Agreement</u>&#8221;) with Aurinia Pharma U.S., Inc., a Delaware corporation (&#8220;<u>Parent</u>&#8221;), and Aurinia Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (&#8220;<u>Merger Sub</u>&#8221;). Pursuant to the Merger Agreement, on May 11, 2026, Merger Sub was merged with and into the Registrant with the Registrant surviving as a wholly owned subsidiary of Parent
        (the &#8220;<u>Merger</u>&#8221;). In the Merger, each share of common stock, par value
        $0.001 per share, of the Company (the &#8220;<u>Shares</u>&#8221;) (other than (i)
        Shares owned or held in the Company&#8217;s treasury immediately prior to the Effective Time, (ii) Shares owned directly or indirectly by Parent or Merger Sub immediately prior to the Effective Time and (iii) Shares held by any stockholder of the
        Registrant who properly exercised appraisal rights under Delaware law) was converted into the right to receive (i) $6.955 per Share in cash and (ii) one non-transferable contractual contingent value right for each Share</font>.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">As a result of the Merger, the Registrant has terminated all offerings of its securities pursuant to the Registration Statements. In accordance with an undertaking made
      by the Registrant in each of the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities that had been registered for issuance that remain unsold at the termination of the offerings, the
      Registrant hereby removes from registration all such securities registered under the Registration Statements that remain unsold as of the date hereof and terminates the effectiveness of the Registration Statements.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
    <div>&#160;</div>
    <div style="text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
      requirements for filing these Post-Effective Amendments to the Registration Statements and has duly caused these Post-Effective Amendments to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Rockville, State of
      Maryland, on May 11, 2026. No other person is required to sign these Post-Effective Amendments to the Registration Statements in reliance on Rule 478 of the Securities Act of 1933, as amended.</div>
    <div> <br>
      </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z57ca4c353fa24bab8c0d48b319faf4d8" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 60%; vertical-align: top;"><br>
          </td>
          <td style="width: 40%; vertical-align: top;">
            <div style="font-weight: bold;">KEZAR LIFE SCIENCES, INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 60%; vertical-align: top;"><br>
          </td>
          <td style="width: 40%; vertical-align: middle;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 60%; vertical-align: top; padding-bottom: 2px;"><br>
          </td>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-indent: -10pt; margin-left: 10pt;">/s/ Michael Hearne</div>
          </td>
        </tr>
        <tr>
          <td style="width: 60%; vertical-align: top;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;">
            <div style="text-indent: -10pt; margin-left: 10pt;">Name: Michael Hearne</div>
          </td>
        </tr>
        <tr>
          <td style="width: 60%; vertical-align: top;" rowspan="1"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;" rowspan="1">
            <div style="text-indent: -10pt; margin-left: 10pt;">Title: Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
